EF 5 (Balversa 5 mg)
Generic Name: erdafitinib
Pill with imprint EF 5 is Brown, Round and has been identified as Balversa 5 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Balversa is used in the treatment of bladder cancer; urothelial carcinoma and belongs to the drug class multikinase inhibitors. Balversa 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EF 5
Balversa
- Generic Name
- erdafitinib
- Imprint
- EF 5
- Strength
- 5 mg
- Color
- Brown
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 59676-0050
Related Images for "EF 5"
More about Balversa (erdafitinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.